Practice Profile: Kerri-Ann Limbeek is a first-chair trial lawyer handling high-value complex patent cases for both plaintiffs and defendants in courts across the country. In January 2024, she won a $57 million patent infringement verdict for the biotech company Ravgen’s prenatal genetic testing patent. In 2022, she also secured $372.5 million in damages (a $272.5 million verdict with a $100 million enhancement) in a separate lawsuit involving the same patent.
Limbeek’s cases involve a broad range of technologies, including pharmaceuticals, medical and surgical devices, consumer products, semiconductor fabrication, computer hardware, software, telecommunications, and video streaming technology. She has also assisted clients in negotiating settlement and license agreements, and counseled clients on strategic patent licensing, international arbitrations, and post-grant proceedings before the Patent Office.
